Vanda Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Vanda Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Vanda Pharmaceuticals Inc Strategy Report
- Understand Vanda Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Vanda Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
07 Dec 2023 | Vanda Pharma Acquires Rights to PONVORY from Actelion Pharma | Asset Transaction |
Vanda Pharmaceuticals Inc
|
Actelion Pharmaceuticals Ltd |
29 Sep 2022 | Vanda Pharma Enters into Co-Development Agreement with OliPass | Partnership | - |
OliPass Corporation
Vanda Pharmaceuticals Inc |
08 Apr 2020 | Vanda Pharma and University of Illinois at Chicago Enter into Partnership to Identify Antivirals against COVID-19 | Partnership | - |
Vanda Pharmaceuticals Inc
University of Illinois at Chicago
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer